⟵ Back to Search Results

BGB-A317-310

Recruiting

Study of Tislelizumab in Combination With Chemotherapy Compared to Chemotherapy Alone for Participants With Urothelial Carcinoma

Beigene Study ID info

BGB-A317-310

ClinicalTrials.gov ID info

NCT03967977

China Drug Trials ID info

CTR20190543

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents

Locations

Study Overview

Sex: All

Age: 18 Years to 75 Years   (Adult, Older Adult)

No Study Documents